Antiplatelet Therapy In Ischemic Heart Disease (eBook)

Stephen D. Wiviott (Autor)

eBook Download: PDF

2009 | 1. Auflage
312 Seiten
John Wiley & Sons (Verlag)
978-1-4443-0334-6 (ISBN)

Infos

This book in the new American Heart Association Clinical Series, explores and explains state-of-the-art use of antiplatelet agents and draws on the expertise of global leaders in antiplatelet therapy. Skillfully organized for fast reference, the book is divided into five parts:

* Concepts in Platelet Physiology, Function, and Measurement

* Pharmacology of Oral Antiplatelet Agents

* Pharmacology of Intravenous Antiplatelet Agents

* Clinical Use of Antiplatelet Agents in Cardiovascular Disease

* Special Circumstances.

Each chapter in the clinical section contains an overview of guidelines, plus specifics on medical and interventional uses.

Clinical cardiologists, platelet biologists, and a wide range of practicing and prospective clinicians in allied fields will find this text an exceptional source of current information.

Autor

Stephen D. Wiviott, MD., Investigator TIMI Study Group, Associate Physician, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Inhalt

Part I Concepts in Platelet Physiology, Function and
Measurement.

1 Platelet physiology and the role of the platelet in ischemic
heart disease.

Robert F. Storey .

2 Laboratory assessment of platelet function and the effects of
antiplatelet agents.

Alan D. Michelson, A.L. Frelinger .

Part II Pharmacology of Oral Antiplatelet Agents.

3 Cyclooxygenase inhibitors.

Nina Chetty Raju, John W. Eikelboom .

4 Aspirin response variability and resistance.

Wai-Hong Chen, Daniel I. Simon .

5 P2Y12 inhibitors: Thienopyridines and direct oral
inhibitors.

Jean-Philippe Collet, Boris Aleil, Christian Gachet, Gilles
Montalescot .

6 Thienopyridine response variability and resistance.

Udaya S. Tantry, Thomas A. Suarez, Paul A. Gurbel .

Part III Pharmacology of Intravenous Antiplatelet
Agents.

7 Pharmacology of intravenous glycoprotein IIb/IIIa
antagonists.

James C. Blankenship, Peter B. Berger .

8 Intravenous P2Y12 inhibitors.

Steven P. Dunn, Steven R. Steinhubl .

9 Antiplatelet effects of thrombin inhibitors and fibrinolytic
agents.

Nicolai Mejevoi, Anjum Tanwir, Marc Cohen .

Part IV Clinical Use of Antiplatelet Agents in Cardiovascular
Disease.

10 Antiplatelet therapy in acute coronary syndrome with ST
elevation.

Christian W. Hamm .

11 Antiplatelet therapy in ST-elevation myocardial
infarction.

Michelle O'Donoghue, Marc S. Sabatine .

12 Antiplatelet therapy in chronic artery disease.

Kamran I. Muhammed, Deepak L. Bhatt .

13 Antiplatelet therapy in peripheral arterial disease.

Esther S. Kim, Heather L. Gornik .

14 Clinical use of antiplatelet agents in cardiovascular
disease: cerebrovascular diseases.

Larry B. Goldstein .

Part V Special Circumstances.

15 Antiplatelet therapy and coronary bypass surgery: risks and
benefits.

A. Burdess, N.L. Cruden, K.A. Fox .

16 Management of antiplatelet therapy for non-cardiac
surgery.

Nisheeth Goel, John F. Canales, James J. Ferguson .

17 Antiplatelet therapy and coronary stents.

Alanna Coolong, Laura Mauri

Rezensionen

"This thorough book addresses the topic in a concise manner. It can be used as a quick reference by busy practitioners or as a teaching guide for students." (Doody's Reviews, June 2009)

Produkt-Details

• Erscheint lt. Verlag: 26.1.2009
• Reihe/Serie: American Heart Association Clinical Series
• Reihe/Serie: American Heart Association Clinical Series
• Sprache: englisch
• Themenwelt: Medizin / Pharmazie ► Allgemeines / Lexika
• Themenwelt: Medizinische Fachgebiete ► Innere Medizin ► Hämatologie
• Themenwelt: Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie
• Schlagworte: Cardiovascular Disease • Kardiovaskuläre Erkrankung • Kardiovaskuläre Erkrankungen • Kardiovaskuläre Erkrankung • Kardiovaskuläre Erkrankungen • Medical Science • Medizin
• ISBN-10: 1-4443-0334-1 / 1444303341
• ISBN-13: 978-1-4443-0334-6 / 9781444303346